Congenital melanocytic nevi occur as a result of in-utero somatic mutations concerning genes that play a role in the mitogen-activated protein kinase (MAPK) pathway (mainly NRAS and BRAF). These mutations lead to the development of cutaneous (and sometimes extracutaneous) mosaicisms.